Multicenter Trial for the Evaluation of a Fixed Dose Combined Tablet for the Treatment of Pulmonary Tuberculosis

The recruitment status of this study is unknown because the information has not been verified recently.

Verified September 2006 by International Union Against Tuberculosis and Lung Diseases.
Recruitment status was Recruiting

Sponsor:

Collaborator:

United States Agency for International Development (USAID)

Information provided by:

International Union Against Tuberculosis and Lung Diseases

ClinicalTrials.gov Identifier:

NCT00216333

First received: September 20, 2005

Last updated: September 12, 2006

Last verified: September 2006

History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	June 2007
Estimated Primary Completion Date:	No date given

No publications provided by International Union Against Tuberculosis and Lung Diseases

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Lienhardt C, Cook SV, Burgos M, Yorke-Edwards V, Rigouts L, Anyo G, Kim SJ, Jindani A, Enarson DA, Nunn AJ; Study C Trial Group. Efficacy and safety of a 4-drug fixed-dose combination regimen compared with separate drugs for treatment of pulmonary tuberculosis: the Study C randomized controlled trial. JAMA. 2011 Apr 13;305(14):1415-23. doi: 10.1001/jama.2011.436. Erratum in: JAMA. 2011 Sep 28;306(12):1327.

To Top